Teva Oncology

Featured Drug Company Program


Teva Cares Foundation

877-237-4881
www.tevacares.org

Teva CORE

888-587-3263
www.TevaCORE.com

The Teva Cares Foundation offers access to oncology medications from Teva Oncology through the Teva Cares Foundation Patient Assistance Program and Teva Comprehensive Oncology Reimbursement Expertise (CORE) program.

Teva Cares Foundation Patient Assistance Program provides oncology medications at no cost to eligible patients who meet certain income and insurance criteria.

Teva CORE is designed to provide reimbursement support program and online tools and resources for oncology medications from Teva Oncology.

Teva CORE can provide assistance with benefit verification, coverage determination, prior authorizations, and letters of medical necessity, as well as personalized support throughout the claims and appeals processes.

For uninsured patients, Teva CORE can identify additional resources to assist patients with the costs of their treatment.

The SYNCare support program is available for patients taking Synribo (omacetaxine mepesuccinate). Services that the program offers include:

  • Arranging for the direct delivery of Synribo to patients
  • Supplying materials for injection, cleanup, and disposal of injection waste
  • A toll-free hotline with trained personnel.
Patients can call 844-796-2273 or can visit www.synribo.com/SYNCare_Support for more information.

For a list of oncology drugs from Teva Oncology see the Table.

Table Teva Oncology Drugs
Drug Indications Patient support programs Contact information
Bendeka
(bendamustine hydrochloride)
Chronic lymphocytic leukemia; indolent B-cell non-Hodgkin lymphoma Teva CORE www.tevacore.com
Teva Cares Foundation Patient Assistance Program www.tevacares.org
Fentora
(fentanyl buccal tablet), CII
Breakthrough pain
in cancer
Teva Cares Foundation Patient Assistance Program www.tevacares.org
Fentora Savings Card www.fentora.com/savings_card
Granix
(tbo-filgrastim)
Severe neutropenia Teva CORE www.tevacore.com
Teva Cares Foundation Patient Assistance Program www.tevacares.org
Synribo
(omacetaxine mepesuccinate)
Chronic myeloid leukemia Teva CORE www.tevacore.com
Teva Cares Foundation Patient Assistance Program www.tevacares.org
SynCare www.synribo.com/syncare_support
Treanda
(bendamustine hydrochloride)
Chronic lymphocytic leukemia; indolent B-cell non-Hodgkin lymphoma Teva CORE www.tevacore.com
Teva Cares Foundation Patient Assistance Program www.tevacares.org
Trisenox
(arsenic trioxide)
Acute promyelocytic leukemia Teva CORE www.tevacore.com
Teva Cares Foundation Patient Assistance Program www.tevacares.org

Eligibility

Teva Cares Foundation Patient Assistance Program

Patients may qualify for the Teva Cares Foundation Patient Assistance Program if they:

  • Are a US resident
  • Have been prescribed Fentora (fentanyl buccal tablet), CII
  • Do not have prescription drug coverage
  • Meet annual household income requirements.
More information about eligibility requirements can be obtained at www.tevacares.org/DoIQualify.aspx or by calling 877-237-4881.

Teva CORE

Patients may qualify for assistance through Teva CORE if they:
  • Have been prescribed an oncology medication from Teva Oncology, including Bendeka (bendamustine hydrochloride), Granix (tbo-filgrastim), Synribo (omacetaxine mepesuccinate), Treanda (bendamustine hydrochloride), or Trisenox (arsenic trioxide)
  • Meet the annual household income requirements.
For more information about eligibility requirements, call 888-587-3263.

Application & Enrollment

Teva Cares Foundation Patient Assistance Program

Drug-specific application forms for the Teva Cares Foundation Patient Assistance Program, available at www.tevacares.org/DownloadApplication.aspx, and the Teva CORE program, available at www.tevacore.com/PDF/Enrollment%20Form.pdf, must be completed and faxed to the number on the enrollment form or mailed directly to the program’s address listed on the form. Proof of income is required from all sources and for all household members, as well as a prescription (if required).

Teva CORE Enrollment

Patients and prescribers must coordinate to complete their designated sections of the application. Prescribers enrolling in the Teva CORE program can fill out a standard application form or can submit the form online through iAssist at https://eprescribe.iassist.com/?style=tevaoncology. iAssist is a tool for applying for financial support and to register patients who are prescribed Teva Oncology medications.

Directions on how to enroll patients in Teva CORE through iAssist are available at https://eprescribe.iassist.com/files/tevaoncology/Teva_CORE_Enrollment.pdf.

Receiving Teva Medications

Depending on the type of medication and route of administration, the drug can either be shipped directly to the patient, the provider, or the treatment facility.